News

Zacks Investment Research on MSN1d
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill
Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
NBC16 on MSN1d
HIV vaccine a closer reality thanks to new HIV PrEP injection
Six months of prevention -- that's how long Lenacapavir, the new drug for HIV prevention lasts.The Food and Drug Administration approved it last month, and desp ...